Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 6Completed 4Terminated 2Not yet recruiting 2Withdrawn 1No longer available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Hepatitis B, Chronic 3Carcinoma, Hepatocellular 3Fibrosis 2Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Tenofovir × Clear all
NCT02650271 2024-01-23

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Guangxi Medical University

Phase 3 Completed
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02129829 2020-09-28

WATCH

Imperial College London

Completed
1,079 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT02081469 2020-02-05

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Chang Gung Memorial Hospital

Phase 4 Completed
100 enrolled

Neoplasms, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡